Rhumbline Advisers lessened its holdings in shares of Sapiens International Co. (NASDAQ:SPNS – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 46,525 shares of the technology company’s stock after selling 665 shares during the quarter. Rhumbline Advisers owned 0.08% of Sapiens International worth $1,250,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. National Bank of Canada FI acquired a new stake in shares of Sapiens International in the third quarter worth $26,000. Blue Trust Inc. boosted its position in Sapiens International by 171.2% during the 4th quarter. Blue Trust Inc. now owns 1,356 shares of the technology company’s stock worth $36,000 after purchasing an additional 856 shares during the period. MQS Management LLC acquired a new stake in Sapiens International in the 3rd quarter valued at $230,000. HighTower Advisors LLC purchased a new position in Sapiens International in the third quarter valued at about $231,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Sapiens International by 74.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,463 shares of the technology company’s stock worth $614,000 after purchasing an additional 7,022 shares in the last quarter. Hedge funds and other institutional investors own 30.73% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. William Blair reiterated a “market perform” rating on shares of Sapiens International in a report on Friday, December 6th. Jefferies Financial Group lowered shares of Sapiens International from a “buy” rating to a “hold” rating and dropped their price objective for the company from $36.00 to $28.00 in a research note on Monday, February 3rd. Needham & Company LLC restated a “buy” rating and issued a $35.00 target price on shares of Sapiens International in a research note on Wednesday, February 19th. Barclays dropped their price target on shares of Sapiens International from $30.00 to $28.00 and set an “underweight” rating on the stock in a research note on Wednesday, February 19th. Finally, StockNews.com cut shares of Sapiens International from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $33.50.
Sapiens International Trading Up 2.5 %
NASDAQ SPNS opened at $27.97 on Thursday. The company has a market capitalization of $1.56 billion, a price-to-earnings ratio of 21.68 and a beta of 1.16. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.24 and a quick ratio of 2.18. Sapiens International Co. has a 12 month low of $25.01 and a 12 month high of $41.22. The company’s fifty day moving average price is $26.72 and its two-hundred day moving average price is $31.08.
Sapiens International (NASDAQ:SPNS – Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The technology company reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.01). The firm had revenue of $134.31 million during the quarter, compared to analyst estimates of $135.89 million. Sapiens International had a return on equity of 17.42% and a net margin of 13.31%. As a group, research analysts predict that Sapiens International Co. will post 1.42 earnings per share for the current fiscal year.
Sapiens International Profile
Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.
Further Reading
- Five stocks we like better than Sapiens International
- Growth Stocks: What They Are, What They Are Not
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Quiet Period Expirations Explained
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Options Trading – Understanding Strike Price
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding SPNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sapiens International Co. (NASDAQ:SPNS – Free Report).
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.